CGC Canopy Growth Corp: Price-to-Projected Revenue Ratio

Corporate emblem and logo of Tweed (CGC)

Canopy Growth is battling oversupply and stringent oversight by building strong consumer brands. A decline in recreational product yields is being offset by a strategic focus on medical extracts. A strategic alliance with Constellation Brands is expanding global distribution. Opening the forward P/S history on GURU.Markets, this chart reflects valuation dynamics where 1.10 represents the metric's baseline.

CGC (Canopy Growth Corp) Market Cap to Future Revenue Ratio history from 07/04/2022 to 11/13/2026

Analytical breakdowns and data insights for company Canopy Growth Corp. (CGC)

- market price and analyst price targets:
Price Chart Canopy Growth Corporation|CGC - Average Forecast Price
- company stock capitalization data:
Market Value Canopy Growth Corp.|CGC - Full Business Value
- book value of equity indicators:
Accounting Value per Share Canopy Growth|CGC - Total Stockholders' Equity|Market Cap to Net Assets Ratio canopygrowth.com|CGC - Aggregate Asset Value
- debt burden and liquidity indicators:
Total Debt to Capital Canopy Growth|CGC - Long-Term Indebtedness to Equity|Short-Term Debt to Equity Canopy Growth|CGC - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Canopy Growth Corp.|CGC - Long-Term Debt|Company Current Liabilities Canopy Growth|Quick Liquidity Indicator canopygrowth.com
- net income and valuation multiples indicators:
CGC - Profit After Payment of Taxes|Projected Future Earnings Canopy Growth|CGC - Company Value to Net Income|Forward P/E Multiple Tweed|CGC - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Canopy Growth Corp.|CGC - Operating profit before depreciation charges|Net earnings per share (EPS TTM) Canopy Growth|CGC - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months canopygrowth.com|CGC - Earnings per share growth this year|Earnings growth forecast for next year Canopy Growth
- revenue and sales details:
CGC - Revenue and Sales Volume|Company Projected Revenue Canopy Growth Corporation|CGC - Market Capitalization-to-Revenue Ratio|Forward P/S Multiple Canopy Growth Corp.
Summary company analysis:CGC (Canopy Growth Corporation)
Product sample of Canopy Growth

To minimize risks amid uncertainty, it is essential for investors to evaluate market capitalization relative to projected sales, which allows for the determination of an objective acquisition value for the asset. By analyzing the forward price-to-sales ratio, one can identify overpayment or hidden issues within the issuer, which is critical for Canopy Growth (CGC) during this period of anticipation for operating profits and regulatory reforms in the US.

Competitor analysis

Price-to-Projected Revenue Ratio Indivior INDV|Collegium Pharma (COLL) - Market Cap to Future Revenue Ratio|CRON - Price-to-Projected Revenue Ratio|Future Price to Revenue HITI|ACB (auroramj.com) - Forward Price-to-Revenue Multiple|Market Cap to Future Revenue Ratio achievelifesciences.com (ACHV)|Forward Price-to-Revenue Multiple SKYE|ANEB: Forward Price to Sales|Forward P/S Multiple INCR|nutriband.com (NTRB) - Projected Price to Revenue|Price-to-Projected Revenue Ratio Nasus Pharma NSRX|Forward Price to Sales IGC|MIRA - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Flora Growth Corp|IMCC (imcannabis.com) - Forward Price-to-Revenue Multiple|Forward Price-to-Revenue Multiple Adial Pharmaceuticals, Inc.|Forward Price-to-Revenue Multiple ARTL|ENSC (Ensysce) - Price to Expected Revenue Ratio|Forward P/S Multiple TTNP|GNLN (Greenlane Holdings, Inc.) - Forward Price to Sales|Forward P/S Multiple INM (InMed Pharma)|AKAN - Forward Price-to-Revenue Multiple|Enveric Biosciences - Forward P/S Multiple|Projected Price to Revenue Bright Green (BGXX)|HPCO: Forward P/S Multiple